Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)
NCT00812864
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Colorectal Cancer
Interventions
DRUG:
Capecitabine
Sponsor
University Hospital, Limoges